Effect of aflibercept in insufficient responders to prior anti-VEGF therapy in neovascular AMD

PURPOSE: Evaluation of three aflibercept injections at 4-week intervals in patients with neovascular AMD showing an “insufficient anatomic response” to prior anti-VEGF therapy with ranibizumab or bevacizumab. METHODS: The retrospective analysis included 96 eyes that had received at least three intra...

Descripción completa

Detalles Bibliográficos
Autores principales: Fassnacht-Riederle, Heidi, Becker, Matthias, Graf, Nicole, Michels, Stephan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2014
Materias:
Retinal Disorders
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4218980/
https://www.ncbi.nlm.nih.gov/pubmed/24614949
http://dx.doi.org/10.1007/s00417-014-2589-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4218980/
https://www.ncbi.nlm.nih.gov/pubmed/24614949
http://dx.doi.org/10.1007/s00417-014-2589-3

Ejemplares similares